Postpartum GLP-1 receptor agonists and SGLT-2 therapies in women with prior gestational diabetes: current evidence and uncertainties
The emerging role of GLP-1 RA and SGLT-2 inhibitors in preventing T2DM after GDM is examined, with uncertainties persist regarding safety in women of reproductive age, use during lactation, optimal timing, and patient selection.